Angle rises sharply on patent award
23rd Aug 2011 12:12
Technology firm incubator Angle saw an acute increase in its share price after one of its subsidiaries was granted a US patent. Angle's 83% owned medical diagnostics company Parsortix has been issued a US patent relating to its technology for particle and cell separation, identification, sorting an
Read moreAngle FY10 Loss Narrows, To Focus On Cash Resources, Cost Cuts
29th Jul 2010 08:21
LONDON (Dow Jones)--Angle PLC (AGL.LN), an international Ventures and Management services company, Thursday reported a much narrowed fiscal 2010 pretax loss and said it continues to focus on the level of cash resources available to it and will continue to reduce its cost base and seek new management
Read moreAngle investment secures high profile partner
26th Jul 2010 17:14
Technology consultancy and investment company Angle says that its portfolio company Geomerics has agreed a corporate partnership with one of the world's leading technology companies. The partner will invest up to £2.3m in Geomerics, of which £1m is dependent on milestones being achieved. Angle cu
Read moreAngle: Geomerics Corporate Partnership With Technology Company
26th Jul 2010 08:24
LONDON (Dow Jones)--Angle PLC (AGL.LN), an international venture management company focusing on the commercialization of technology and innovation, said Monday that its portfolio company Geomerics Ltd, which specializes in computer games middleware, has agreed to a corporate partnership with a techn
Read moreSmall caps round-up: Judges Scientific, Terra Catalyst, DCC
16th Jul 2010 11:42
Judges Scientific said trading activity during the six-month ended 30 June remained robust and benefited from a healthy opening order book, strong order intake and favourable exchange rates. Order intake during the half-year was much stronger than in the comparable period of 2009. Terra Catalyst Fu
Read moreAngle: NeuroTargets Makes Progress, Gets GBP3.8M Phase 2 Funding
16th Jul 2010 07:31
LONDON (Dow Jones)--Angle PLC (AGL.LN), an international venture management company focusing on the commercialization of technology and innovation, Friday announces strong progress with NeuroTargets, its 25% portfolio company specializing in the relief of neuropathic pain, with the Wellcome Trust ag
Read moreGrid finance chief sells again
24th Sep 2009 17:14
Gas and electricity network operator National Grid has sailed through the turbulence of the past year relatively unscathed. The share price now is still lower than this time in 2008, but has bounced strongly since April and finance director Steve Lucas is taking advantage to sell his second chunk
Read moreLondon close: Ten out of ten for Footsie
24th Jul 2009 17:13
The FTSE 100 index made it ten days of rises in a row, despite tailing off towards the close as investors looked to bank profits ahead of the week-end. It capped the best rally by the blue-chip index in five years. The rise was achieved despite dismal gross domestic product data. UK output contract
Read moreLondon afternoon: Financials find favour
24th Jul 2009 14:11
Footsie eased back a little over the lunchtime session but thanks to firm financials the blue-chip index continues to shrug off this morning's gloomy data on gross domestic product (GDP). UK output contracted 0.8% between April and June after a 2.4% decline in the first quarter, according to the Of
Read moreLondon midday: London shrugs off GDP shock
24th Jul 2009 11:54
After a shaky opening the market is moving steadily ahead, despite receiving a jolt from much worse than expected gross domestic product (GDP) figures. Output contracted 0.8% between April and June after a 2.4% decline in the first quarter, according to the Office for National Statistics' flash est
Read moreAngle confident of management services division
24th Jul 2009 08:38
Venture management firm Angle posted strong profitability in the management services business for the year but various provisions pushed the group into losses. "Angle is successfully reshaping its Management services business and has done much to protect its portfolio against clearly adverse market
Read more